mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.1 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.2 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |